窑Clinical Research窑
Hypopharyngeal carcinoma has a substantially poorer prognosis of all malignant tumors of the head and neck, with metastasis to regional lymph nodes even at early stages. However, the metastatic profile of regional lymph nodes in hypopharyngeal carcinoma is only generally reported in the published reports of headandneck tumors 1, 2 . Dedicated studies about regional lymph node metastasis in patients with hypopharyngeal carcinoma are hardly seen, and research on retropharyngeal lymph node metastasis is even rarer. Therefore, by analyzing computed tomography (CT) and magnetic resonance imaging (MRI) data, our study investigated cervical and retropharyngeal lymph node metastases and their correlations in patients with hypopharyngeal carcinoma to provide an evidence basis for clinical treatments.
By searching the system of medical chart data at our hospital, data on 207 patients with pathologically confirmed hypopharyngeal carcinoma between August 2000 and March 2009 were collected. Among these patients, 114 had pretreatment CT data and another 11 had pretreatment MRI data. Among the 114 patients with pretreatment CT, 6 patients had other concomitant headandneck tumors and 31 had an inadequate scanning range. After excluding the patient data mentioned above, 77 patients with CT data and an adequate Analysis of cervical and retropharyngeal lymph node metastases in the patients with hypopharyngeal carcinoma with computed tomography and magnetic resonance imaging scanning range and 11 patients with MRI data were included in the study. These cases included 66 patients with pyriform sinus carcinomas, 20 with posterior hypopharyngeal wall carcinomas, and 2 with postcricoid carcinomas. Of these patients, 84 were men, 4 were women, and they were aged between 25 years and 79 years, with a median age of 55 years. Regarding the pathologic profiles, the cancer was rated as squamous epithelial carcinoma in 68 patients and as carcinoma in situ in 20 patients. According to the 2002 tumornodemetastasis (TNM) staging system of the International Union Against Cancer (UICC), the T and N staging of 88 patients is detailed in Table 1 .
During CT scanning, the patient was in a supine position, with the neck bending backward to ensure that the cervical vertebra were parallel to the examination couch. The patient was told to breathe normally when scanning from the skull base to the clavicular head was performed.
Of these patients, 7 were immediately given contrast enhanced scanning by the bispiral scanner Elscint Twin Flash CT. Both the slice gap and thickness were 5 mm, with a pitch of 1 : 1.
In the other 70 patients, plain scanning and intravenous contrastenhanced scanning were given in a routine fashion by PHILIPS Brilliance 16 CT. After the plain scanning, contrastenhanced sc anning was performed on the same slices. Both the slice gap and thickness were 5 mm and reconstruction slice thickness was 2 mm. After reconstruction and fusion, the images were reviewed and analyzed by DICOM software.
A total of 11 patients were given MRI scanning. Scanning was performed using a SE sequence transversely, sagittally, and coronally. The scanning range started from the base of the skull and ended at the lower margin of the clavicular head. Variables for the scanning were: T 1 WI TR/TE = 400600/1525 ms; T 2 WI TR/TE = 18003000/90150 ms; slice thickness/slice gap = 5 mm/0.5 mm. All the patients were given 0.1 mmol/kg of GdDTPA via intravenous injection after plain scanning. Then contrastenhanced T 1 WI scanning was performed transversely, sagittally, and coronally on the same slices as in the plain scanning. Images were reviewed and measured by DICOM software.
In this study, the images were reviewed by two to three clinical physicians together with imaging specialists. Tumor site and the scope of involvement were observed and the staging was determined. Diagnostic criteria for metastatic lymph nodes were: (1) on transversal images, the maximum diameters were 逸 5 mm for retropharyngeal lymph nodes, 逸 11 mm on level IIa, and 逸 10 mm on other levels; (2) on enhanced scanning, the boundary of the lymph node was circularly enhanced, along with the central necrotic area, regardless of the size of the lymph nodes; (3) lymph nodes were either confluent or showed more than 3 lymph nodes in the lymph drainage area of the primary tumor, and the diameters of these lymph nodes were between 810 mm on the transversal image; and (4) extracapsular invasion of lymph nodes was present 38 .
The correlations between lymphnode metastases in the various levels were tested by 字 2 test and logistic multivariate analysis. < 0.05 indicated statistical significance. All the statistical analyses were performed with SPSS15.0 software.
Figure 1 CT images of the lymph node metastases of hypopharyngeal carcinoma
A, enhanced CT shows the left retropharyngeal lymph node (3 mm 伊 3 mm) in front of the carotid sheath; B, enhanced CT shows the bilateral retropharyngeal lymph node intumesce (11 mm 伊 10 mm) with ring reinforcement; C, enhanced CT shows bilateral level鄄 IIa lymph node intumesce, the sizes are 9 mm 伊 11 mm and 9 mm 伊 9 mm, respectively.
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Among the 88 patients with hypopharyngeal carcinoma, the incidence of cervical lymphnode metastasis was 73.9% (65/88). The most frequently seen metastatic sites were levels IIa and IIb. The distribution of lymphnode metastases in different cervical levels is shown in Table 2 .
Since patients in our study had mostly locally advanced disease, with less frequent occurrences of disease at early stages (T1 and T2), stages T1 and T2 were combined as local earlystage disease, and stages T3 and T4 were considered local advancedstage disease. Included in the statistical analyses were local staging, bilateral cervical lymphnode metastasis, and lymphnode metastases at various levels.
The 字 2 test showed a significant correlation between level IIb and both bilateral cervical lymph node metastasis and retropharyngeal lymph node metastasis ( = 0.021 and = 0.028, respectively), and between level Ib and lymph node metastases at levels III and IV ( = 0.021 and = 0.001, respectively).
Logistic multivariate analysis showed a significant correlation between bilateral cervical lymph node metastasis and retropharyngeal lymph node metastasis ( = 0.016, = 4.846, 95% CI = 1.34817.420). LevelVI lymph node metastasis was significantly correlated to levelIV lymph node metastasis ( = 0.033, = 8.556, 95% CI = 1.19061.512).
Metastasis in the cervical lymph nodes is extremely common in patients with hypopharyngeal carcinoma. Previous data mainly derive from pathologic analysis on surgical samples, but largescale case reports have been rare. In addition, since the retropharyngeal lymph nodes are generally not included in the lymphnode dissection for hypopharyngeal carcinoma, study reports about these are even rarer.
With the progress in modern imaging in recent years, CT and MRI have been widely used in detecting and diagnosing malignant tumors of the head and neck. Relevant studies suggest that CT and MRI can clearly reveal the condition of cervical lymph nodes, and their accuracy in determining metastasis therein can be as much as 80% 90% 3, 9 . At present, CT or MRIbased evaluations of regional lymph node metastasis in patients with hypopharyngeal carcinoma is a considerably reliable and feasible method.
Our study revealed that the incidence of lymph node metastasis in patients with hypopharyngeal carcinoma was 73.9%, and that lymph node metastasis at the various levels was not correlated to local staging, which was consistent with the published literature 1013 . This suggested that, for hypopharyngeal carcinoma, metastasis could occur even at early stages, and thus patients with both earlystage and advanced disease should be given preventive treatment for metastasis at regional lymph nodes.
Some scientists have also studied the pattern and distribution of metastasis in the cervical lymph nodes of patients with hypopharyngeal carcinoma. Candela . 14 summarized the data from Memorial SloanKettering Cancer Center and demonstrated that levelI and levelV lymph node involvement was always accompanied by lymphnode involvement at other levels. Moreover, only one (0.3%) patient had skip metastasis. Buckley . 15 suggested that levelI and levelV lymph node metastasis was not common even in N+ patients. Yu . 16 analyzed the surgical samples from the radical neck dissections of 32 patients with laryngeal carcinoma and 18 patients with hypopharyngeal carcinoma (that is, a total of 50 patients) whose cervical lymph node metastasis was confirmed by palpation, CT scanning, or both, and found that cervical lymph node metastasis was mainly distributed at levels II and III, less frequently at levels IV and VI, and rarely at levels I and V. Shah 17 found that, in patients with cN0 disease, pN+ was only seen at levels II and III, and lymph nodes at levels I and V were not found to be involved. In patients with cN1cN3 disease, pN+ lymph nodes could be found at levels IV, but mostly at levels II and III. The French Head and Neck Study Group18 studied 313 patients from 12 hospitals and demonstrated that upper cervical metastasis was most common (55% ), followed by midcervical (28% ), and lower cervical metastasis (17%). In addition, some scientists 19 also reported that cervical lymph node metastasis was mainly distributed at levels II and III in patients with N0 hypopharyngeal carcinomas and at levels II, III, and IV in patients with N+ disease. It is therefore considered that patients with N + disease should be treated with radical cervical lymphnode dissection, while patients with N0 disease can be treated with regional (levels II and III) lymphnode dissection.
Among the patients in this study, the highest incidence of lymph node metastasis was seen at levels IIa, IIb, and III (61.4%, 44.3% , and 37.5% , respectively). Of patients with lymph node metastasis, the incidence at level IIa was 83.1% and level IIb was 60.0% . The total incidence at level II was 93.8% and 50.8% at level III. The incidence of lymph node metastasis at levels I, IV, V, and VI, and the retropharyngeal area were 3.4%, 9.1%, 3.3%, 5.7%, and 13.6%, respectively, which were all lower than those in levels II, III, or II + III, suggesting that lymph node metastasis at levels I, IV, V, and VI and the retropharyngeal area generally occurred in patients at later Nstages.
In further analyses on the correlations between metastasis at the various levels, univariate analysis showed significant correlations between levelIV lymph node metastasis and lymphnode metastasis at levels Ib and III. Based on the analyses mentioned above, levelIV lymph node metastasis often occurred after levelIII lymph node metastasis, and both were seen in patients at later Nstages. However, multivariate analysis showed no correlation between level Ib and levelIII or levelIV lymph node metastasis. This might be due to the small sample size. Furthermore, multivariate analysis also showed a correlation between levelVI lymph node metastasis and levelIV lymph node metastasis, suggesting that levelVI lymph node metastasis might occur after levelIV lymph node metastasis. Studies have suggested that postcricoid carcinoma was more prone to levelIV lymph node metastasis 20 , but there were only two patients with postcricoid carcinomas in our study, so this concept will need to be investigated further in a larger sample. As for levelVa and levelVb lymph node metastasis, the incidence was merely 1% 2% in this study, and was thus not included in the analysis.
The incidence of retropharyngeal lymph node metastasis in patients with hypopharyngeal carcinoma varies from study to study. In 1964, Ballantyne 21 reported that the incidence of retropharyngeal lymph node metastasis was 44% in patients with pharyngeal wall carcinoma. It should be noted that the pharyngeal wall carcinoma in this study was not limited to tumors that originated from the lower pharyngeal wall, but also included oropharyngeal wallderived tumors. In 1994, Hasegawa . 22 studied 13 patients with hypopharyngeal carcinoma and found retropharyngeal lymph node metastasis in 8 patients (62% ). In this study, all patients were rated with N2a disease or above with regard to Nstaging, and none of them had N1 disease. In 1995, in the study on the correlation between retropharyngeal lymph node metastasis and prognosis of headandneck tumors, McLaughlin . 23 revealed that no retropharyngeal lymph node metastasis was found in 55 patients with negative cervical lymph nodes. In 81 patients with positive cervical lymph nodes, 7 (9% ) showed retropharyngeal lymph node metastasis. In 2004, PrinsBraam . 24 mentioned that no retropharyngeal lymph node metastasis was found in their study on the distance between the highest involved lymph node and the skull base in 58 patients with cervical lymph nodepositive oropharyngeal or hypopharyngeal carcinoma (40 oropharyngeal carcinomas and 18 hypopharyngeal carcinomas) using CT scanning. Therefore, retropharyngeal lymph node metastasis in patients with hypopharyngeal carcinoma varies vastly across different studies.
Our study found retropharyngeal lymph node metastasis in 12 patients (13.6% ), of which 6 were metastases from carcinomas of the posterior pharyngeal wall, accounting for 30.0% of all carcinomas of the posterior pharyngeal wall. Another 6 patients had pyriform sinus carcinomas, accounting for 9.2% of all pyriform sinus carcinomas. All the r etropharyngeal lymph node metastasis was seen in patients with N2 disease and was accompanied by lymph node metastasis at other cervical levels. Univariate analysis showed significant correlations between retropharyngeal lymph node metastasis and levelIIb and bilateral cervical lymph node metastasis, while multivariate analysis suggested significant correlations between bilateral cervical lymph node metastasis and retropharyngeal lymph node metastasis. This indicated bilateral cervical lymph node metastasis was a risk factor for retropharyngeal lymph node metastasis. But some scientists 25 have also suggested that retropharyngeal lymph node metastasis could occur even in patients with hypopharyngeal carcinoma without lymph node metastasis at other cervical levels. This idea was based on the published studies by Mancuso . 4 and Hasegawa . 22 . In 1983, Mancuso reported that, among 11 patients with retropharyngeal lymph node metastasis, 2 had hypopharyngeal carcinomas, 1 had T4N3 disease with deep superior cervical lymph node metastasis, 1 had retropharyngeal lymphnode recurrence after total laryngectomy for hypopharyngeal carcinoma, without lymph node metastasis at other cervical levels. However, local tumor conditions and regional invasion at the time of first diagnosis were not specified in the study report. Another patient with retropharyngeal lymph node metastasis but no metastasis at other cervical lymph nodes in the study was a breast cancer survivor. In 1994, Hasegawa reported that one out of two patients with pN0 oropharyngeal carcinoma had positive retropharyngeal lymph nodes, but none of the three patients with pN0 hypopharyngeal carcinoma had positive retropharyngeal lymph nodes. It was also noted in the study report that no retropharyngeal lymph node metastasis was found in patients with cN0 disease. The authors believe this evidence is not enough to support that retropharyngeal lymph node metastasis can be found even in patients with hypopharyngeal carcinoma without lymph node metastasis at other cervical levels.
In conclusion, regional lymph node metastasis can be seen even in the early stages of hypopharyngeal carcinoma, with certain metastatic patterns but rarely skip metastasis. The highest incidence of lymph node metastasis is seen at levels II and III, but no patients with lymph node metastasis solely in levels I, IV, V, or VI, or the retropharyngeal area were found. Bilateral cervical lymph node metastasis may be a risk factor for retropharyngeal lymph node metastasis. The study results have certain implications for selecting the scope of clinical treatment for patients with hypopharyngeal carcinoma and shall encourage further investigation. 
